Ultraviolet radiation (UVR) exposure may influence risk of non-Hodgkin lymphoma (NHL) through vitamin D, with antineoplastic effects mediated through the vitamin D receptor (VDR). To explore the role of vitamin D in NHL risk and the potential interaction with UVR, the authors genotyped 10 VDR polymorphisms in 2,448 NHL patients and 1,981 controls from Denmark and Sweden who were recruited in 1999-2002. Odds ratios and 95% confidence intervals were computed with logistic regression. P values were 2-sided. Most VDR variants (e.g., rs731236/TaqI, rs15444410/BsmI) were not associated with overall risk of NHL, but there was some evidence of a positive association between rs4760655 and follicular lymphoma risk (nominal P trend ¼ 0.004, corrected P trend ¼ 0.24). There was no support for an effect of interaction between VDR variants and UVR exposure on risk of overall NHL or B-cell lymphoma subtypes. However, there was some evidence that rs731236 altered associations between UVR and T-cell NHL risk; while increasing UVR frequency lowered T-cell NHL risk among rs731236 TT carriers, an elevated risk was observed among rs731236 CC carriers (nominal P interaction 0.008, corrected P interaction 0.12). VDR does not appear to harbor major determinants of NHL risk, except perhaps for follicular lymphoma. Possible heterogeneity in effects of UVR exposure on T-cell lymphoma risk by VDR rs731236 genotype merits further investigation.
Ultraviolet radiation (UVR) exposure from the sun was reported to decrease risk of non-Hodgkin lymphoma (NHL) in several recent epidemiologic studies (1) (2) (3) (4) (5) . Because sun exposure is the primary source of vitamin D in humans and its biologically active forms have antineoplastic effects, the observed inverse association with risk of NHL may be mediated through UVR-induced vitamin D activation (6) . Studies of vitamin D levels in serum or vitamin D intake and NHL risk provide additional, though not unanimous, support for this hypothesis (7) (8) (9) .
The vitamin D receptor (VDR) protein is a transcriptional activator affecting expression of many genes related to cell growth, differentiation, and apoptosis (10) , and it is expressed in lymphocytes (11) . Polymorphic variation in the VDR gene may affect intracellular vitamin D response (12) ; for example, the rs10735810 (FokI) single nucleotide polymorphism (SNP) alters the transcription initiation site and has been associated with risk of various solid cancers (13) . The rs731236 (TaqI) and rs1544410 (BsmI) SNPs appear to alter gene expression and mRNA stability (14) . The rs731236 (TaqI) SNP was recently reported to be associated with risk of diffuse large B-cell lymphoma (15) and to interact with UVR exposure in risk of follicular lymphoma (16) . To further explore the potential role of vitamin D in lymphomagenesis, we investigated 10 VDR variants and their interaction with UVR in risk of NHL and major subtypes in a Danish-Swedish case-control study including 4,429 persons.
MATERIALS AND METHODS
The Scandinavian Lymphoma Etiology (SCALE) Study is described in detail elsewhere (2) . In brief, SCALE was a population-based case-control study encompassing residents of Sweden and Denmark aged 18-74 years, recruited in 1999-2002. Patients with a first incident NHL were identified through national hospital-based networks of physicians. Controls were randomly sampled from nationwide population registers and were frequency-matched to the cases by age (in 10-year intervals), sex, and country. Persons with previous organ transplantation, human immunodeficiency virus infection, or hematopoietic malignancy or who could not speak Danish or Swedish sufficiently were excluded. Following informed consent, 81% of eligible cases and 71% of eligible controls participated in a telephone interview including questions on UVR exposure (2) , and 85% of participating cases and 65% of participating controls provided a blood specimen. The present study encompasses participants who were interviewed, gave blood, and were of second-generation Nordic origin (17) . Ethical approval was granted by national scientific ethics committees.
The genotyping methods used have recently been described (17) . For most study participants, genomic DNA was isolated from white blood cells with the QIAGEN Maxi Kit (VWR International AB, Stockholm, Sweden). For a proportion of the Swedish controls, DNA was prepared from dried whole blood spots on filter paper and wholegenome amplified with the AmpliQ Genomic Amplifier Kit (Ampliqon A/S, Skovlunde, Denmark). Because the overall genotype concordance between amplified and genomic DNA was 99% (17), we used amplified DNA when genomic DNA was not available. Thirty-two samples were not available for genotyping.
To estimate genetic variation in VDR, we first selected 3 validated SNPs based on previous reports of associations with risk of NHL (rs731236, rs1544410 (15, 16) , and rs10735810 (15)). Secondly, from genetic databases (US National Center for Biotechnology Information (www.ncbi.nih.gov); International HapMap Project, phase II (http://hapmap.ncbi.nlm.nih.gov/)), we chose supplementary tagging SNPs with a minor allele frequency greater than 5% and r 2 0.8, with the aim of improving gene coverage. There were 76 available markers identified using the described selection criteria, and we tagged 35 of these (46% coverage) with 11 of 12 selected SNPs (rs731236 was unavailable in HapMap phase II), with a mean r 2 of 0.95. Samples were genotyped with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Sequenom Inc., San Diego, California) (17) . A success rate of 85% or more was considered satisfactory; 1 SNP (rs10735810) had an unacceptable success rate among the Danish participants and was therefore analyzed statistically only among the Swedes. Regenotyping of 5% of the study samples resulted in 99% concordance. Calculations of Hardy-Weinberg equilibrium were conducted among the controls using the v 2 test; genotype frequencies among controls were considered not to deviate from Hardy-Weinberg equilibrium if P > 0.05/12 (divided by the number of SNPs); 2 SNPs were not in Hardy-Weinberg equilibrium and were excluded. Nine SNPs were included in the final analysis of both countries. Genotyping was validated using 14 trio families (42 persons in total) with HapMap genotype data. Concordance analyses with the HapMap data, as well as analysis of parent-offspring compatibility with the produced genotypes, were performed; there was 100% concordance for all investigated SNPs. Some samples were excluded because of a low genotyping completion rate (<50%, n ¼ 228) or labeling errors (n ¼ 2). A low genotyping completion rate threshold was used because of a difference between genomic and amplified DNA samples (rate 80% for over 90% of genomic samples but only for 50% of amplified samples). As a safeguard against potentially lower quality of the amplified DNA, we repeated some statistical analyses after restricting the analyses to persons for whom genomic DNA was used for genotyping (75).
We computed odds ratios and 95% confidence intervals as estimates of the relative risk of NHL overall and NHL subtypes using unconditional logistic regression, with major allele homozygosity used as the referent category. Trend per allele was tested with the Cochran-Armitage test. Interaction between SNPs and 3 measures of UVR exposure was assessed in models with and without an interaction term. Genotype analyses were adjusted for country of residence, and interaction analyses were additionally adjusted for sex and age (matching variables). We performed multilocus tests of association, comparing models with and without investigated genotype covariates. Although it does not explicitly assign alleles to chromosomes, this is described as a powerful haplotype test of association in tightly linked regions (18) . P values were 2-sided and were corrected for multiple comparisons with the Bonferroni method by multiplying the uncorrected P value by the number of analyses performed (45 main-effects analyses þ 15 interaction analyses). Statistical analyses were conducted using STATA 10.1 (Stata Corporation, College Station, Texas).
RESULTS
The final analyses encompassed 2,448 patients with incident NHL and 1,981 controls (Table 1) . Minor allele frequencies of studied VDR variants were similar to those in previous reports on Caucasian populations (Table 2 ) (www.hapmap.org; 14). None of the variants were associated with risk of overall NHL, diffuse large B-cell lymphoma, chronic lymphocytic leukemia (Table 3) , or T-cell lymphoma (data not shown). The rs4760655 variant was associated with a 60% increase in risk of follicular lymphoma (Table 3 ; nominal P trend ¼ 0.004, corrected P trend ¼ 0.24), and the odds ratio was unaltered upon restriction to subjects with genomic DNA (data not shown). The rs2283342 variant was also associated with elevated risk of follicular lymphoma in the overall analysis (Table 3; nominal P trend ¼ 0.01), but the association disappeared when the analysis was restricted to subjects with genomic DNA (data not shown). Haplotypes based on 4 adjacent SNPs at a time were not associated with overall NHL risk (data not shown).
In analyses of the combined effects of rs731236 genotypes (previously reported to interact with UVR in risk of follicular lymphoma (16)) and UVR exposure, there was no statistically significant interaction with respect to risk of overall NHL or follicular lymphoma (Table 4) . However, the inverse association between UVR and risk of NHL and follicular lymphoma previously observed in our study was restricted to rs731236 TT carriers, while increasing UVR frequency among CC homozygotes appeared, if anything, to increase risk. For T-cell lymphoma, a stronger pattern of differential associations with UVR across rs731236 genotypes was observed (nominal P interaction 0.008 (Table 3) ); it was no longer significant, however, after correction for multiple comparisons (for sunbathing 5-10 years previously, corrected P interaction ¼ 0.48; for sunbathing vacations abroad, corrected P interaction ¼ 0.12; and for sunbathing at age 20 years, corrected P interaction ¼ 0.18). When analyses were restricted to participants with genomic DNA, similar results were obtained.
DISCUSSION
In this large, population-based, and ethnically homogeneous case-control study, there was no evidence that the studied VDR variants constitute major determinants of risk of NHL overall or common NHL subtypes, with the potential exception of follicular lymphoma. Our results for rs4760655 and follicular lymphoma could suggest that variation in the 5# promoter region of VDR affects susceptibility to this specific NHL subtype, but they could also be due to chance. Our results further suggest a possible interaction between sunbathing history and rs731236 (TaqI) genotypes in risk of T-cell lymphoma, with some evidence of a beneficial effect of frequent UVR among major-allele homozygotes but a harmful effect among minor-allele homozygotes.
In our previous study of sunbathing and other UVR exposure measures and risk of NHL in the same population (2), we observed a protective effect of UVR on risk of B-cell NHL but not T-cell NHL. If the presently suggested interaction reflects true biologic variation and not just chance, combined effects of UVR and VDR genotype may vary by lymphoma cell type. Possible explanations for differing interaction patterns by B-/T-cell lineage could include variation in the frequency of VDR expression and transcriptional effects of vitamin D, in combination with differences in the inherent immunoregulatory roles of B-and T-lymphocytes (19) .
In a US study (16) , the rs731236 and rs1544410 (BsmI) variants were not associated with risk of overall NHL or major B-cell subtypes. However, an interaction was reported between UVR and rs731236 in risk of follicular lymphoma. Among persons with low sun exposure, rs731236 minorallele homozygosity was associated with a 6-to 10-fold increased risk of follicular lymphoma compared with majorallele homozygosity (16) . This interaction pattern is different from what we observed, although follicular lymphoma was indicated as potentially associated with VDR variation in both studies. In an Australian case-control study (15) , a positive association was observed between VDR rs731236 and rs1544410 and risk of diffuse large B-cell lymphoma, but interaction with UVR exposure was not investigated. The intronic rs4760655 variant potentially linked to risk of follicular lymphoma in our study is located in the 5# promoter region of VDR and is in linkage disequilibrium with a functional SNP at the Cdx2 binding site (rs11568820; D# ¼ 1, r 2 ¼ 0.1 in a pairwise comparison) (14) , although the 2 variants appear to belong to different haplotype blocks (www.hapmap.org). In the 3# untranslated region, rs731236 and rs1544410 are in strong linkage disequilibrium (20) . Different sets of alleles in this region have been associated with VDR mRNA expression level and stability, with consequences for the number of VDR proteins expressed in target cells and for intracellular vitamin D Table continues response (14); rs731236 T and rs1544410 G alleles have been correlated with lower levels of VDR mRNA expression, and C and A, respectively, have been correlated with higher activity (20) . The present results would thus be consistent with a reduction in T-cell lymphoma risk by high UVR exposure among persons with low-activity VDR alleles. Our study had several strengths, including its large size, the population-based design, and the ability to examine associations with NHL subtypes. Importantly, the study participants were of homogeneous ethnic background, which minimized bias due to population stratification. However, the power to detect modest genetic effects and to robustly determine gene-environment interaction was still limited. Therefore, we may have failed to detect some true associations while observing some nominally statistically significant associations due to chance alone. Upon adjustment for multiple testing, our results were no longer statistically significant. The investigated SNPs did not fully characterize common variation in the VDR gene, and thus an association between other VDR variants and NHL risk cannot be ruled out. In addition, a risk association with common variation in VDR does not necessarily imply an etiologic role of vitamin D, since VDR has functions that are independent of vitamin D (21) . Our questionnaire aimed to characterize UVR exposure during summer and overall throughout the year, but a recent investigation suggested that UVR exposure/vitamin D status during the winter months may be more relevant (8) . Hence, more detailed assessment of seasonal UVR exposure would have been desirable. In conclusion, this study does not provide support for the investigated VDR variants as important determinants of risk of NHL or major subtypes, except perhaps follicular lymphoma. Consequently, the study also provides no additional strong evidence for a role of vitamin D in risk of B-cell NHL. However, we found some evidence of an interaction between VDR rs731236 (TaqI) and UVR exposure in risk of T-cell lymphoma, which merits further study in larger pooled data sets. Given the increasing recognition of the importance of vitamin D for both immunity and cancer, further studies of different measures of vitamin D status, including seasonal UVR, in relation to NHL risk are warranted.
